Pharmaceutical

Valneva’s single-dose chikungunya vaccine authorised in Brazil

Valneva has received marketing authorisation from the Brazilian Health Regulatory Agency for its single-dose chikungunya vaccine, Ixchiq.

Apr 16, 2025 - 06:00
Valneva’s single-dose chikungunya vaccine authorised in Brazil
Valneva has received marketing authorisation from the Brazilian Health Regulatory Agency for its single-dose chikungunya vaccine, Ixchiq.
Read the original article

Tags:

Previous Article

Ironwood’s shares sink as FDA demands new trial for lead drug

Next Article

Pfizer Decides Against Pursuing Lead Obesity Asset Amid Liver Safety Concerns

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: More hospitals are offering child care. But they shouldn’t have to

Opinion: More hospitals are offering child care. But th...

May 31, 2023

Senate committee launches bipartisan investigation into private equity ownership of hospitals

Senate committee launches bipartisan investigation into...

Dec 7, 2023

STAT+: Pharmalittle: Three big drugmakers spent less on lobbying after leaving PhRMA; EMA reviews CRO over data concerns

STAT+: Pharmalittle: Three big drugmakers spent less on...

Jul 24, 2023